Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

levodopa

levodopa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Inbrija POWDER, INHALATION 42 mg      
levodopa POWDER, ORAL      
Comments:

Restricted to Pediatric Endocrinology for growth hormone deficiency testing.

 

Weight (kg)

Levodopa Dose (mg)

<15

125

15-30

250

30-40

375

>40

500

Inbrija is classified as non-formulary. Initiation should be deferred to the outpatient setting and inpatients may use their own Inbrija inhalers.

 

Reviewed: 27 Feb 2018, July 2020 (Inbrija)

Last updated: Aug. 7, 2020






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved